Divi's Laboratories share news, announcements and annual reports
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹9,558.50.
29 Oct: open ₹9,563.00, high ₹9,685.50, low ₹9,534.00
- Next results date: the board meets on 7 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,56,549 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 87.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 15.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,95,25859.7% delivered
Divi's Laboratories share news and announcements
636 announcements, routine notices left out, newest first. Page 2 of 13.
Feb 2025
3 Feb · Management
3 Feb · Board meeting
3 Feb · Results
Jan 2025
28 Jan · Analysts
23 Jan · Board meeting
2 Jan · Commencement of commercial production/operations
Dec 2024
5 Dec · News Verification
The exchange asked on 5 Dec 2024
4 Dec · Legal
Nov 2024
9 Nov · Board meeting
9 Nov · Results
1 Nov · Analysts
1 Nov · Analysts
Oct 2024
29 Oct · Board meeting
Sep 2024
14 Sep · Rating
Aug 2024
3 Aug · Board meeting
3 Aug · Results
Jul 2024
27 Jul · Analysts
25 Jul · Board meeting
16 Jul · Corporate action
15 Jul · Meeting
Jun 2024
22 Jun · Management
22 Jun · Management
May 2024
25 May · Corporate action
25 May · Management
25 May · Results
20 May · Analysts
Apr 2024
25 Apr · Updates
Mar 2024
4 Mar · Meeting
Feb 2024
10 Feb · Management
10 Feb · Board meeting
10 Feb · Results
2 Feb · Analysts
Jan 2024
30 Jan · Board meeting
3 Jan · Updates
Dec 2023
Nov 2023
6 Nov · Board meeting
6 Nov · Results
Oct 2023
28 Oct · Analysts
26 Oct · Board meeting
Sep 2023